|
1 |
Antibody Therapies for Progressive Multiple Sclerosis and for Promoting Repair
Enthalten in Neurotherapeutics 14.3.2022: 1-11
|
|
|
2 |
Charakterisierung von T-Zellen und T-Zell-Rezeptoren bei entzündlichen neurologischen Erkrankungen
Amft, Michaela. - München : Universitätsbibliothek der Ludwig-Maximilians-Universität, 2021
|
|
|
|
3 |
First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
Enthalten in Journal of neurology 11.6.2021: 1-4
|
|
|
|
4 |
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity
Ostkamp, Patrick. - Augsburg : Universität Augsburg, 2020
|
|
|
|
5 |
Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis
Graetz, Christiane. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2019
|
|
|
|
6 |
Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society
Enthalten in Journal of neurology 17.2.2016: 1-22
|
|
|
|
7 |
Inclusion body myositis
Ivanidze, Jana. - Augsburg : Universität Augsburg, 2011
|
|
|
|
8 |
Schwerpunkt Forschungsfreiheit
Enthalten in Gegenworte 1.0
|
|
|
|
9 |
Von Tieren und Forschern
Enthalten in Gegenworte 4
|
|
|
|
10 |
Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
Enthalten in Journal of neuroinflammation Bd. 8, 26.10.2011, Nr. 1, date:12.2011: 1-9
|
|
Administration
